Benign causes of 18-FDG uptake on whole body imaging-Reference-Cited by-同舟云学术

Benign causes of 18-FDG uptake on whole body imaging

Published:1998-10 Issue:4 Volume:28 Page:352-358
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Stadalnik Robert C.,Bakheet Siema M.,Powe John

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference67 articles.

1. Cost effectiveness of PET imaging in clinical oncology;Valk;Nucl Med Biol,1996

2. PET and 18F-FDG in oncology: A clinical update;Conti;Nucl Med Biol,1996

3. Clinical oncology update: The emerging role of positron emission tomography: Part 2;Wahl,1997

4. Normal physiological and benign pathological variants of 18-Fluoro-2-Deoxyglucose positron emission tomography scanning: Potential for error in interpretation;Cook;Sem Nucl Med,1996

5. Pituitary adenoma with seizures: PET demonstration of reduced glucose utilization in the medial temporal lobe;Bairamian;J Comput Assisst Tomogr,1986

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of incidental focal breast uptake on fluorine-18 fluorodeoxyglucose PET/computed tomography studies: an experience in a high-load center of Spain;Nuclear Medicine Communications;2021-02-05

2. PET-CT in Immunocompromised Status;PET-CT in Infection and Inflammation;2020-12-08

3. Acute Findings on FDG PET/CT: Key Imaging Features and How to Differentiate Them from Malignancy;Current Radiology Reports;2020-09-12

4. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma;American Journal of Surgical Pathology;2020-08-05

5. The value of late phase imaging with FDG-PET/CT in liver metastases of colorectal carcinoma;Journal of Health Sciences and Medicine;2020-03-15